CR2 and B-cell chronic lymphocytic leukemia: Using established ELISA protocols, we analysed 50 normal blood donor control (BDC) samples and 50 CLL samples for reactivity with recombinant proteins (CD21, CD35 and CD46) or factor H (FH) isolated from serum.